scispace - formally typeset
D

David J. Wilkinson

Researcher at Boston Children's Hospital

Publications -  45
Citations -  607

David J. Wilkinson is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Medicine & Matrix metalloproteinase. The author has an hindex of 13, co-authored 40 publications receiving 430 citations. Previous affiliations of David J. Wilkinson include University of Liverpool & Eaton Corporation.

Papers
More filters
Journal ArticleDOI

Outcomes in distal hypospadias: A systematic review of the Mathieu and tubularized incised plate repairs

TL;DR: There is no clear consensus on the ideal method of repair for distal hypospadias and both the Mathieu and TIP techniques have been shown to have low rates of postoperative complications.
Journal ArticleDOI

Isolation of Enteric Nervous System Progenitor Cells from the Aganglionic Gut of Patients with Hirschsprung's Disease.

TL;DR: The derivation of enteric nervous system progenitors in the aganglionic gut region of Hirschprung’s patients not only means that this tissue is a potential source of cells for future autologous transplantation, but it also raises the possibility of inducing the differentiation of these endogenous cells in situ to compensate for the Aganglionosis.
Journal ArticleDOI

Foreskin preputioplasty and intralesional triamcinolone: a valid alternative to circumcision for balanitis xerotica obliterans

TL;DR: The results show a good outcome for most boys undergoing foreskin preputioplasty and intralesional triamcinolone for BXO, but rates of meatal stenosis may be reduced.
Journal ArticleDOI

Recent advances in understanding the regulation of metalloproteinases.

TL;DR: A series of recent studies are highlighted that describe how MMP-13 activity, and in fact that of other metalloproteinases, is in part controlled by receptor-mediated endocytosis, which provides a plethora of novel regulatory mechanisms, besides direct inhibition, which with renewed vigour could provide further therapeutic opportunities for regulating the activity of this class of important enzymes.